Department of Gastrointestinal Surgery, Akershus University Hospital, Lørenskog, Norway.
Institute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo, Norway.
Br J Surg. 2017 Sep;104(10):1382-1392. doi: 10.1002/bjs.10567. Epub 2017 Jun 20.
Recent randomized trials demonstrated that laparoscopic lavage compared with resection for Hinchey III perforated diverticulitis was associated with similar mortality, less stoma formation but a higher rate of early reintervention. The aim of this study was to compare 1-year outcomes in patients who participated in the randomized Scandinavian Diverticulitis (SCANDIV) trial.
Between February 2010 and June 2014, patients from 21 hospitals in Norway and Sweden presenting with suspected perforated diverticulitis were enrolled in a multicentre RCT comparing laparoscopic lavage and sigmoid resection. All patients with perforated diverticulitis confirmed during surgery were included in a modified intention-to-treat analysis of 1-year results.
Of 199 enrolled patients, 101 were assigned randomly to laparoscopic lavage and 98 to colonic resection. Perforated diverticulitis was confirmed at the time of surgery in 89 and 83 patients respectively. Within 1 year after surgery, neither severe complications (34 versus 27 per cent; P = 0·323) nor disease-related mortality (12 versus 11 per cent) differed significantly between the lavage and surgery groups. Among the 144 patients with purulent peritonitis, the rate of severe complications (27 per cent (20 of 74) versus 21 per cent (15 of 70) respectively; P = 0·445) and disease-related mortality (8 versus 9 per cent) were similar. Laparoscopic lavage was associated with more deep surgical-site infections (32 versus 13 per cent; P = 0·006) but fewer superficial surgical-site infections (1 versus 17 per cent; P = 0·001). More patients in the lavage group underwent unplanned reoperations (27 versus 10 per cent; P = 0·010). Including stoma reversals, a similar proportion of patients required a secondary operation (28 versus 29 per cent). The stoma rate at 1 year was lower in the lavage group (14 versus 42 per cent in the resection group; P < 0·001); however, the Cleveland Global Quality of Life score did not differ between groups.
The advantages of laparoscopic lavage should be weighed against the risk of secondary intervention (if sepsis is unresolved). Assessment to exclude malignancy (although uncommon) is advised. Registration number: NCT01047462 ( http://www.clinicaltrials.gov).
最近的随机试验表明,与切除术相比,腹腔镜灌洗治疗希氏 III 级穿孔性憩室炎与相似的死亡率、较少的造口形成有关,但早期再次干预的发生率更高。本研究旨在比较参与斯堪的纳维亚憩室炎(SCANDIV)试验的患者 1 年的结果。
2010 年 2 月至 2014 年 6 月,来自挪威和瑞典 21 家医院的疑似穿孔性憩室炎患者参加了一项比较腹腔镜灌洗和乙状结肠切除术的多中心 RCT。所有术中确诊为穿孔性憩室炎的患者均纳入改良意向治疗分析 1 年结果。
199 名入组患者中,101 名随机分配至腹腔镜灌洗组,98 名分配至结肠切除术组。分别有 89 名和 83 名患者在手术时确诊为穿孔性憩室炎。术后 1 年内,两组严重并发症发生率(分别为 34%和 27%;P=0.323)和疾病相关死亡率(分别为 12%和 11%)无显著差异。在 144 例脓性腹膜炎患者中,严重并发症发生率(分别为 27%和 21%;P=0.445)和疾病相关死亡率(分别为 8%和 9%)相似。腹腔镜灌洗与更多的深部手术部位感染相关(32%和 13%;P=0.006),但与较少的浅表手术部位感染相关(1%和 17%;P=0.001)。灌洗组更多患者需要进行计划外再次手术(27%和 10%;P=0.010)。包括造口反转在内,需要二次手术的患者比例相似(28%和 29%)。灌洗组 1 年后造口率较低(灌洗组 14%,切除术组 42%;P<0.001);然而,两组克利夫兰全球生活质量评分无差异。
腹腔镜灌洗的优势应与二次干预的风险(如果感染未得到解决)相权衡。建议评估以排除恶性肿瘤(尽管少见)。注册号:NCT01047462(http://www.clinicaltrials.gov)。